These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 680625)

  • 1. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F; Neuwirth R; Berg G
    Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term therapy with benzbromarone in uric arthritis].
    Bröll H; Sochor H; Tausch G; Eberl R
    Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1976 Oct; 101(43):1568-70. PubMed ID: 991731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
    Matzkies F; Berg G; Minzlaff R
    Fortschr Med; 1977 Jul; 95(27):1748-50. PubMed ID: 332605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of benziodarone and benzbromarone on the uric acid level in the blood and urine and on the incidence of gout attacks].
    Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(3):287-92. PubMed ID: 6999575
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzbromarone therapy in management of refractory gout.
    Kumar S; Ng J; Gow P
    N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A; Giudicelli CP
    S Afr Med J; 1981 May; 59(20):701-6. PubMed ID: 7221794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 15. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E; Brzozowska-Jurkowska AM
    Reumatologia; 1980; 18(1):61-7. PubMed ID: 6994191
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR; Dreykluft HR; Leonhardt H
    Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D; Hesse A; Strenge A; Vahlensieck W
    Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A; Giudicelli CP
    Sem Hop Ther; 1976; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.